Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

22nd Century Group Inc (XXII)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 349,508
  • Shares Outstanding, K 124,380
  • Annual Sales, $ 16,600 K
  • Annual Income, $ -13,030 K
  • 36-Month Beta 2.26
  • Price/Sales 20.68
  • Price/Cash Flow N/A
  • Price/Book 4.73
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.07
  • Most Recent Earnings -0.03 on 11/09/17
  • Next Earnings Date 11/08/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    SIC-2111 Cigarettes

    Tobacco

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.03
  • Growth Rate Est. (year over year) +3,330,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.56 +10.94%
on 10/04/18
3.29 -13.68%
on 10/10/18
+0.28 (+10.94%)
since 09/14/18
3-Month
2.22 +27.93%
on 08/21/18
3.29 -13.68%
on 10/10/18
+0.08 (+2.90%)
since 07/13/18
52-Week
1.92 +47.92%
on 04/24/18
4.44 -36.04%
on 01/23/18
+0.04 (+1.43%)
since 10/13/17

Most Recent Stories

More News
FDA Lead Scientist Discusses 22nd Century's SPECTRUM(R) Research Cigarettes in Public Webcast

22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company focused on tobacco harm reduction and Very Low Nicotine tobacco, announced today that on October 11, 2018, Dr....

XXII : 2.84 (+1.07%)
North American Legal Cannabis Market Gains Momentum With Canadian Legalization

According to data provided by IMARC, the North America legal cannabis market reached a value of more than USD 8 Billion in 2017. The market is projected to reach a value of around USD 35 Billion by 2023...

CLSH : 0.9830 (-0.71%)
CBDS : 5.6600 (+28.93%)
EMHTF : 3.9200 (+4.73%)
ACBFF : 11.6800 (+11.03%)
ITHUF : 5.7700 (+5.87%)
STZ : 223.71 (-0.88%)
XXII : 2.84 (+1.07%)
IAN.CN : 7.550 (+7.86%)
Cannabis Market Expected to Grow With Incorporation of Online Retailers

According to research published by Technavio, the legal cannabis market is estimated to grow at a steady CAGR of about 24% until 2021. The increasing popularity of cannabidiol (CBD) oil products is a major...

CLSH : 0.9830 (-0.71%)
CBDS : 5.6600 (+28.93%)
IVITF : 1.4129 (+9.57%)
EMHTF : 3.9200 (+4.73%)
XXII : 2.84 (+1.07%)
22nd Century Receives Order for 3.6 Million SPECTRUM(R) U.S. Government Research Cigarettes

22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company focused on tobacco harm reduction and Very Low Nicotine tobacco, announced today that the National Institute...

XXII : 2.84 (+1.07%)
Biotech and Cannabis Firms to Watch as Acquisition, Investment, and Licensing Season Begins

FN Media Group Presents Microcapspeculators.com News Commentary

CVSI : 5.9000 (+13.46%)
APHQF : 15.3500 (+4.78%)
TLRY : 165.64 (+11.69%)
XXII : 2.84 (+1.07%)
BRTX : 1.4790 (+4.15%)
Cannabis Market Set to Grow as Canadian Competition Increases

According to a research report by Mordor Intelligence, the global cannabis market was valued at USD 7.7 Billion in the year 2016 and is expected to reach USD 65 Billion by the year 2023, while registering...

CANN : 3.7580 (+11.51%)
IVITF : 1.4129 (+9.57%)
CROP.CN : 0.475 (unch)
ITHUF : 5.7700 (+5.87%)
CRXPF : 0.3676 (unch)
XXII : 2.84 (+1.07%)
IAN.CN : 7.550 (+7.86%)
Analysis: Positioning to Benefit within Cboe Global Markets, Sanderson Farms, National Oilwell Varco, Brighthouse Financial, VeriSign, and 22nd Century Group -- Research Highlights Growth, Revenue, and Consolidated Results

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Cboe Global Markets, Inc. (NASDAQ:CBOE),...

BHF : 43.48 (+1.14%)
SAFM : 98.38 (+0.88%)
NOV : 42.18 (+0.64%)
XXII : 2.84 (+1.07%)
CBOE : 99.26 (-0.85%)
BHFWV : 64.57 (+0.89%)
VRSN : 142.51 (-1.02%)
22nd Century Files 2018 Second Quarter Report

22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is focused on tobacco harm reduction, Very Low Nicotine tobacco, and hemp/cannabis research, announced today...

XXII : 2.84 (+1.07%)
Unique Company Taking the Cannabis Boom Global

LONDON, July 25, 2018 /PRNewswire/ --

NTEC : 4.98 (+3.32%)
APH.TO : 19.90 (+4.13%)
SPRWF : 1.6800 (+3.70%)
APHQF : 15.3500 (+4.78%)
FIRE.VN : 2.180 (+4.81%)
XXII : 2.84 (+1.07%)
OGRMF : 6.3000 (+9.37%)
OGI.VN : 8.200 (+9.33%)
22nd Century Reports on New Responses to the FDA's Nicotine Reduction Plan

22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tobacco harm reduction and Very Low Nicotine tobacco, today highlights two important ...

XXII : 2.84 (+1.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade XXII with:

Business Summary

22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products...

See More

Key Turning Points

2nd Resistance Point 2.94
1st Resistance Point 2.89
Last Price 2.84
1st Support Level 2.78
2nd Support Level 2.72

See More

52-Week High 4.44
Fibonacci 61.8% 3.48
Fibonacci 50% 3.18
Fibonacci 38.2% 2.88
Last Price 2.84
52-Week Low 1.92

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar